SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.80+0.3%Nov 21 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (13918)7/2/2000 7:31:40 AM
From: Robert K.  Read Replies (1) of 17367
 
Cacaito. First let me say right off congrats on your call and second you "can be" a excellent poster when you want to be. What I see is a almost hatred for xoma and a anti-xoma bia's. When you want you can have very interesting thoughts and opinions as some recent notes reveal. Because of your tone, I question your objectivity though. Again, I congradulate you on you lilly call but dont make the mistake that lilly has won. They may win a sepsis drug or they may not. The battle is not over, although I am sure the market calls it as a lilly victory party. So you can properly or improperly assume that lilly will be the first to market a sepsis drug as the market has assumed. All eyes are on lilly for sure, no doubt there. I remember way back
when Antril (anti-il-1) was a sure thing too. I say this to you. you can probably expect the unexpected and the unexpected is always the biggest surprise/event.
I do not know how events will play out, but I bet things will get even more interesting. No facts really, just IMO as usual. Standard K
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext